- Home
- MVBF vs CATX Comparison
MVBF vs CATX Comparison
Compare MVBF & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVBF
- CATX
- Stock Information
- Founded
- MVBF 1997
- CATX 1983
- Country
- MVBF United States
- CATX United States
- Employees
- MVBF N/A
- CATX N/A
- Industry
- MVBF Major Banks
- CATX Medical/Dental Instruments
- Sector
- MVBF Finance
- CATX Health Care
- Exchange
- MVBF Nasdaq
- CATX Nasdaq
- Market Cap
- MVBF 278.3M
- CATX 239.0M
- IPO Year
- MVBF N/A
- CATX N/A
- Fundamental
- Price
- MVBF $23.21
- CATX $3.35
- Analyst Decision
- MVBF Buy
- CATX Strong Buy
- Analyst Count
- MVBF 3
- CATX 11
- Target Price
- MVBF $24.67
- CATX $12.90
- AVG Volume (30 Days)
- MVBF 52.3K
- CATX 1.9M
- Earning Date
- MVBF 07-28-2025
- CATX 08-11-2025
- Dividend Yield
- MVBF 3.02%
- CATX N/A
- EPS Growth
- MVBF N/A
- CATX N/A
- EPS
- MVBF 1.46
- CATX N/A
- Revenue
- MVBF $146,101,000.00
- CATX $1,471,000.00
- Revenue This Year
- MVBF N/A
- CATX N/A
- Revenue Next Year
- MVBF $14.22
- CATX N/A
- P/E Ratio
- MVBF $15.44
- CATX N/A
- Revenue Growth
- MVBF N/A
- CATX N/A
- 52 Week Low
- MVBF $15.59
- CATX $1.60
- 52 Week High
- MVBF $25.24
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- MVBF 80.99
- CATX 50.66
- Support Level
- MVBF $20.26
- CATX $3.54
- Resistance Level
- MVBF $22.72
- CATX $4.44
- Average True Range (ATR)
- MVBF 0.52
- CATX 0.40
- MACD
- MVBF 0.16
- CATX -0.04
- Stochastic Oscillator
- MVBF 99.08
- CATX 18.57
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.